More on PRLD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)
- Holders

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Prelude Therapeutics Inc. (NQ:PRLD)
Delayed: 4.32 -0.03 (0.69%)
Prev. Close $4.35  
Open$4.38 
52 Wk High$ 
52 Wk Low$ 
Day High$4.64 
Day Low$4.16 
P/E N/A  
EPS$ 
Volume1,076,627 

Friends, Peers and Foes (?): ONCY, INCY, IMNM, ALXO, ERAS (more...)

Jun 10, 2026 04:45 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: 667, L.P.
Jun 10, 2026 04:16 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: Dorton Katina
Jun 10, 2026 04:16 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: Babler Martin
Jun 10, 2026 04:14 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: Bonita David P
Jun 10, 2026 04:13 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: Sandor Victor
Jun 10, 2026 04:12 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: FRIEDMAN PAUL A
Jun 10, 2026 04:11 PM Form 8-K Prelude Therapeutics For: Jun 09
May 15, 2026 05:07 AM Goldman Sachs Starts Prelude Therapeutics (PRLD) at Early-Stage Biotech
May 12, 2026 04:02 PM Prelude Therapeutics (PRLD) PT Raised to $10 at Jefferies
May 12, 2026 07:19 AM Form 10-Q Prelude Therapeutics For: Mar 31
View All Articles

Entities mentioned with PRLD

View All Entities